We store cookies on your device to make sure we give you the best experience on this website. I'm fine with this - Turn cookies off
Switch to an accessible version of this website which is easier to read. (requires cookies)

Dominic Raab spills the beans ( Twice)

December 3, 2019 5:08 PM

Raab admits no-deal Brexit is still on the table

When asked on the Today Programme this morning whether the government is still prepared to crash out of the EU with no deal in 2020, the Foreign Secretary Dominic Raab said "yes absolutely."

Responding, Shadow Liberal Democrat Brexit Secretary Tom Brake said:

"Dominic Raab has been forced to admit the Tories' dirty secret: a no-deal Brexit is still on the table.

"Boris Johnson's extreme Brexit plan would lead to us crashing out of the EU by the end of 2020, egged on by Donald Trump who wants to exploit a weakened UK.

"People deserve better. It's not too late to stop the damage to our economy, NHS and public finances from a Johnson Trump Brexit.

"This election is a chance to stop Boris, stop Brexit, and build a brighter future

In the Independent Dominic Raab has also admitted the US will be able to charge higher prices for drugs bought by the NHS after Brexit, but insisted the prospect is "hugely unlikely".
Asked if Washington would be free to "jack up prices", the Foreign Secretary replied: "The Americans will take their decisions."

He then claimed: "I think it's hugely unlikely, why would they do that?" - prompting Sky News interviewer Adam Boulton to say: "To get more money that's why.

The comments come after documents released by Labour revealed that drug pricing has been discussed by US and UK negotiators in exploratory talks
Mr Raab again insisted the NHS would not be "on the table for negotiations" in the US-UK trade deal Boris Johnson is desperate to secure after leaving the EU.

The government would "walk away" rather than sign up to an agreement that put the health service at risk, he said.
However, the US has demanded "full market access" in the NHS and is known to want to end the ability of Nice, which regulates medicine prices in the UK, to block drugs it does not consider value for money.

The Trump administration also wants to change patent law, potentially paving the way for US drug firms to demand higher prices for their medicines and over a longer period of time